United States· US:73555-502_76183831-b710-4be2-a6a7-9349dd501830
Revuforj
A revumenib product containing revumenib citrate, registered in United States by Syndax Pharmaceuticals, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- REVUMENIB CITRATE
- Manufacturer
- Syndax Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- L01XX87
- ATC class
- Revumenib
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11735555020030 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (73555-502-00)
- ndc1173555-502-00
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01XX87
Revumenib, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1f9f300-5ff5-471a-a8a6-978d06f16c13 GET /v1/drugs/f1f9f300-5ff5-471a-a8a6-978d06f16c13?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "160",
"substance": "REVUMENIB CITRATE",
"productndc": "73555-502",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA218944",
"marketing_category": "NDA"
}See everything about revumenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.